TRI logo

TRI

Thomson Reuters Corp

$135.00
+$3.30(+2.51%)
9
Overall
--
Value
9
Tech
--
Quality
Market Cap
$60.37B
Volume
1.20M
52W Range
$131.41 - $218.42
Target Price
$193.65

Company Overview

Mkt Cap$60.37BPrice$135.00
Volume1.20MChange+2.51%
P/E Ratio27.3Open$131.23
Revenue$7.3BPrev Close$131.70
Net Income$2.2B52W Range$131.41 - $218.42
Div Yield2.38%Target$193.65
Overall9Value--
Quality--Technical9

No chart data available

About Thomson Reuters Corp

Thomson Reuters Corporation operates as a content and technology company in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates through five segments: Legal Professionals, Corporates, Tax and Accounting Professionals, Reuters News, and Global Print. The Legal Professionals segment offers research and workflow products focusing on legal research and integrated legal workflow solutions that combine content, tools, and analytics to law firms and governments. The Corporates segment provides a suite of content-driven technologies, including generative AI and integrated compliance workflow solutions to small businesses and multinational organizations. The Tax and Accounting Professionals segment offers research and workflow products to tax, audit, and accounting firms. The Reuters News segment provides business, financial, and international news to media organizations, professional, and news consumers through Reuters News Agency, Reuters.com, Reuters Events, Thomson Reuters products, and to financial firms. The Global Print segment offers legal and tax information primarily in print format. The company was formerly known as The Thomson Corporation and changed its name to Thomson Reuters Corporation in April 2008. The company was founded in 1799 and is headquartered in Toronto, Canada. Thomson Reuters Corporation is a subsidiary of The Woodbridge Company Limited.

Sector: Financial Services
Industry: Capital Markets

Latest News

Kepler Capital Keeps Their Buy Rating on Trigano SA (TGNOF)

Kepler Capital analyst Alessandro Cuglietta maintained a Buy rating on Trigano SA on November 20 and set a price target of €174.00. The company’s s...

TipRanks Auto-Generated Intelligence Newsdesk2 days ago

Trinity Biotech Secures WHO Approval for Offshore Manufacturing of HIV Test

TipRanks Auto-Generated Newsdesk2 days ago

TrivarX Limited Faces First Strike on Remuneration Report at AGM

TipRanks Australian Auto-Generated Newsdesk3 days ago

Red Light Holland Advances Psilocybin Research with Larger Shipment to Irvine Labs

TipRanks Canadian Auto-Generated Newsdesk4 days ago

Trinity Biotech Collaborates to Enhance Prostate Cancer Test

TipRanks Auto-Generated Newsdesk5 days ago
ABCD
1SymbolPriceChangeVol
2TRI$135.00+2.5%1.20M
3
4
5
6

Get Thomson Reuters Corp Data in Excel

Stream real-time data directly to your spreadsheets

BUY NOW
Stock data provided by MarketXLS.